Breaking News: BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering in 2024! PHILADELPHIA and Vancouver, British Columbia, Dec. 11, 2024 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced the pricing of an underwritten…

A Lesson in Corporate Responsibility: The Kyverna Therapeutics Class Action Lawsuit Introduction On December 11, 2024, Bragar Eagel & Squire, P.C., a reputable stockholder rights law firm, made an announcement that caught the attention of the financial world. A class action lawsuit had been filed against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) in the United States…

URGENT: ASP Isotopes Inc. Faces Lawsuit for Securities Law Violations – How You Can Help as an Affected Shareholder Overview LOS ANGELES, CA / ACCESSWIRE / December 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ASP Isotopes Inc. (“ASP Isotopes” or “the…

Americas Gold and Silver’s Proposed Acquisition: ISS and Glass Lewis Recommend Shareholder Approval In a recent announcement, Americas Gold and Silver Corporation disclosed that leading independent proxy advisory firms, Institutional Shareholder Services (“ISS”) and Glass Lewis & Co., LLC (“Glass Lewis”), have both issued reports urging shareholders to vote in favor of all resolutions related…

Expanding Opportunities for Bilingual Education The Kemper Foundation has made a significant announcement that is sure to have a positive impact on Title I elementary schools in under-resourced communities. The Read Conmigo Grant Program, which has already been successful in supporting educators, is now expanding to offer school-wide grants to further advance dual-language education for…

The Impact of Cassava Sciences Investigation on Investors Investigation Commenced Levi & Korsinsky has recently started investigating Cassava Sciences, Inc. (NASDAQ: SAVA) for potential violations of federal securities laws. This investigation comes after Cassava Sciences announced on November 25, 2024, that the topline results from the Phase 3 ReThink-ALZ study of simufilam in mild-to-moderate Alzheimer’s…

Tesla’s Bullish Run: A Closer Look at the Strong Fundamentals Introduction Since the bullish call on Tesla, the electric car company has witnessed a staggering 77% rally. This impressive growth can be attributed to the strong fundamentals supporting Tesla’s business model. As a result, Tesla remains a ‘Strong Buy’ in the eyes of many investors….